Indole and benzimidazole derivatives as dual 5-ht2a and 5-ht6 receptor antagonists
EP3520781A1
A pharmaceutical composition comprising metamizole, drotaverine, and caffeine
EP3511334A1
1,2,3',5'-tetrahydro-2'h-spiro[indole-3,1'-pyrrolo[3,4-c]pyrrole]-2,3'-dione compounds as therapeutic agents activating tp53
EP3437636A1
Pharmaceutical composition comprising ezetimibe
EP3388063A1
Treatment of a bacterial vaginal infection
EP3243506A1
Pharmaceutical composition
CA2947134A1
Compounds comprising 1,1',2,5'-tetrahydrospiro[indole-3,2'-pyrrole]-2,5'-dione system as inhibitors p53-mdm2 protein-protein interaction
AU2014310317A1
Duloxetine enteric coated tablet
WO2015004610A1
1,5-dihydropyrrol-2-one derivatives as inhibitors of p53-mdm2/mdm4 protein-protein interaction
WO2014141094A1
Anticancer conjugate
SG11201503441XA
A pharmaceutical composition containing an ace inhibitor and a calcium channel blocker
WO2014057436A2
Anticancer conjugate
CN104220421A
Sulphonamide derivatives of benzylamine for the treatment of cns diseases
AU2012360086A1
Anticancer fusion protein
EP2497464A2
Pharmaceutical composition of imatinibe methanesulphonate and a process for its manufacture
NZ609219A
Anticancer fusion protein
SG10201509676UA
Anticancer fusion protein
CN104529999A
Arylosulfonamides for the treatment of CNS diseases
